https://www.news-medical.net/news/2004/05/24/1833.aspx
Trial shows Daclizumab therapy improves multiple sclerosis outcome
May 13, 2009 - A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab...
multiple sclerosistrialshowsdaclizumabtherapy
https://clarivate.com/life-sciences-healthcare/report/emthcg0003-2017-biopharma-multiple-sclerosis-emerging-therapies-zinbryta-daclizumab-us-wave-3-2017/
Multiple Sclerosis | Emerging Therapies | Zinbryta (daclizumab) | US | Wave 3 | 2017 | Clarivate
With its launch in August 2016, Zinbryta became the 14thdisease-modifying therapy (DMT) approved to treat relapsing forms of multiple sclerosis (MS) in the...
multiple sclerosisemerging therapieszinbryta
https://pubmed.ncbi.nlm.nih.gov/19364933/
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of...
clinicaltrials.gov Identifier: NCT00001934.